Live from the NIH registry
Studies recruiting near Little Rock right now
Top 25 of 503 recruiting studies, sorted by proximity — each links to its official registry page
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Arkansas Children's Hospital — Little Rock, Arkansas (4.1 mi)
· Sponsor: National Cancer Institute (NCI)
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
Medical Investigations — Little Rock, Arkansas (4.1 mi)
· Sponsor: Medtronic MiniMed, Inc.
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
University of Arkansas for Medical Sciences — Little Rock, Arkansas (4.1 mi)
· Sponsor: SWOG Cancer Research Network
A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects
Iron Deficiency Anemia
Phase 3
Interventional 75 participants sought
Arkansas Children's Hospital — Little Rock, Arkansas (4.1 mi)
· Sponsor: AMAG Pharmaceuticals, Inc.
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — Little Rock, Arkansas (4.1 mi)
· Sponsor: AstraZeneca
Juveena Hydrogel System Feasibility Study for Heavy Menstrual Bleeding (HMB)
Heavy Menstrual Bleeding
N/A
Interventional 7 participants sought
Applied Research Center of Arkansas — Little Rock, Arkansas (4.1 mi)
· Sponsor: Rejoni Inc.
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
Chronic Migraine
Phase 3
Interventional 420 participants sought
Preferred Research Partners /ID# 270389 — Little Rock, Arkansas (4.1 mi)
· Sponsor: AbbVie
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
University of Arkansas for Medical Sciences — Little Rock, Arkansas (4.1 mi)
· Sponsor: NRG Oncology
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
Arkansas Cardiology — Little Rock, Arkansas (4.1 mi)
· Sponsor: Duke University
Study of the Shockwave Medical SkyRunner Carotid Intravascular Lithotripsy (IVL) System for the Treatment of Calcified Carotid Arteries Prior to Trans-Carotid Stenting (SKYWARD Trans-Carotid IDE [Investigational Device Exemption] Study)
Carotid Artery Calcification, Carotid Artery Diseases
N/A
Interventional 185 participants sought
Arkansas Heart Hospital — Little Rock, Arkansas (4.1 mi)
· Sponsor: Shockwave Medical, Inc.
Pharmacokinetics of Sulopenem Etzadroxil Plus Probenecid in Adolescents
Pharmacokinetics After Oral Intake
Phase 1
Interventional 12 participants sought
Medical facility — Little Rock, Arkansas (4.1 mi)
· Sponsor: Iterum Therapeutics, International Limited
A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States
Non-Muscle Invasive Bladder Neoplasms
N/A
Observational 150 participants sought
Arkansas Urology — Little Rock, Arkansas (4.1 mi)
· Sponsor: Janssen Research & Development, LLC
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Neuroblastoma
Phase 2
Interventional 93 participants sought
Arkansas Children's Hospital — Little Rock, Arkansas (4.1 mi)
· Sponsor: Giselle Sholler
Comparison of Uncomplicated Candidemia Therapy Duration in Children
Invasive Candidiasis
N/A
Interventional 420 participants sought
Arkansas Children's Hospital — Little Rock, Arkansas (4.1 mi)
· Sponsor: Arkansas Children's Hospital Research Institute
A Study of SGT-003 Gene Therapy in Ambulant Males With Duchenne Muscular Dystrophy (IMPACT DUCHENNE)
Duchenne Muscular Dystrophy
Phase 3
Interventional 80 participants sought
Arkansas Children's Hospital — Little Rock, Arkansas (4.1 mi)
· Sponsor: Solid Biosciences Inc.
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Plasma Cell Myeloma
Phase 3
Interventional 510 participants sought
CARTI Cancer Center — Little Rock, Arkansas (4.1 mi)
· Sponsor: SWOG Cancer Research Network
Supervision in Substance Use Disorder Treatment Programs
Self Efficacy, Burnout, Professional
N/A
Interventional 43 participants sought
University of Arkansas for Medical Sciences — Little Rock, Arkansas (4.1 mi)
· Sponsor: University of Arkansas
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
Cardiovascular Disease and Lipoprotein(a)
Phase 3
Interventional 5,700 participants sought
Cardiology and Medicine Clinic PA — Little Rock, Arkansas (4.1 mi)
· Sponsor: Novartis Pharmaceuticals
Registry Study for Radiation Therapy Outcomes
Neoplasms
N/A
Observational 50,000 participants sought
Proton Center of Arkansas — Little Rock, Arkansas (4.1 mi)
· Sponsor: Proton Collaborative Group
Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)
Locally Advanced Cervical Cancer
Phase 3
Interventional 800 participants sought
Research Site — Little Rock, Arkansas (4.1 mi)
· Sponsor: AstraZeneca
Efficacy of Fusidic Acid 1% in the Treatment of Bacterial Conjunctivitis
Bacterial Conjunctivitis
Phase 3
Interventional 400 participants sought
Baxis Site 04 — Little Rock, Arkansas (4.1 mi)
· Sponsor: Baxis Pharmaceuticals, Inc.
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
Hot Flashes, Breast Cancer
Phase 2
Interventional 110 participants sought
Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences — Little Rock, Arkansas (4.1 mi)
· Sponsor: University of Arkansas
SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors
Hemophilia A With Inhibitor, Hemophilia B With Inhibitor
Phase 4
Interventional 55 participants sought
Arkansas Center for Bleeding Disorders — Little Rock, Arkansas (4.1 mi)
· Sponsor: American Thrombosis and Hemostasis Network
The Society for Obstetric Anesthesia and Perinatology Research Network General Anesthesia Registry
Cesarean Delivery, General Anesthesia
N/A
Observational 5,000 participants sought
University of Arkansas — Little Rock, Arkansas (4.1 mi)
· Sponsor: Yale University
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
Non-small Cell Lung Cancer
Phase 2
Interventional 630 participants sought
Research Site — Little Rock, Arkansas (4.1 mi)
· Sponsor: AstraZeneca